| |
| |
|
| Insider
Information: |
Casamento Charles J |
| Relationship: |
Director |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
268,219 |
|
|
Indirect Shares
|
138,482 |
|
|
| Direct
Value |
$12,902 |
|
|
|
Indirect Value
|
$80,743 |
|
|
| Total
Shares |
406,701 |
|
|
| Total
Value |
$93,645 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
RespireRx Pharmaceuticals Inc |
RSPI |
Director |
2007-11-30 |
15,000 |
2005-02-08 |
0 |
Premium* |
|
|
Astex Pharmaceuticals Inc |
ASTX |
Director |
2013-05-03 |
0 |
2005-08-05 |
0 |
Premium* |
|
|
Osteologix, Inc. |
OLGXF |
Officer, Director |
2006-05-24 |
57,420 |
|
0 |
Premium* |
|
|
Vivus Inc |
VVUS |
Director |
2013-01-25 |
87,125 |
2011-12-06 |
0 |
Premium* |
|
|
International Stem Cell Corp |
ISCO |
Director |
2018-06-21 |
14,431 |
2012-05-29 |
0 |
Premium* |
|
|
Relmada Therapeutics, Inc. |
RLMD |
Director |
2022-04-01 |
0 |
2020-09-01 |
21,484 |
Premium* |
|
|
First Wave Biopharma Ord Shs |
FWBI |
Director |
2024-01-02 |
19,937 |
2020-03-19 |
116,998 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
Director |
2019-08-09 |
71,920 |
2018-11-15 |
0 |
Premium* |
|
|
Paxmedica, Inc. |
PXMD |
Director |
2024-03-12 |
2,386 |
2022-10-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VVUS |
Vivus Inc |
Director |
– • – |
2011-12-06 |
4 |
OE |
$4.23 |
$105,750 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2011-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
62,125 |
0 |
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2012-03-12 |
4 |
S |
$20.14 |
$745,217 |
D/D |
(37,000) |
61,000 |
0 |
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2012-03-12 |
4 |
OE |
$7.67 |
$328,460 |
D/D |
37,000 |
65,000 |
0 |
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2012-04-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
36,000 |
26,125 |
0 |
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2012-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
66,000 |
0 |
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2012-08-20 |
4 |
S |
$20.63 |
$165,060 |
D/D |
(8,000) |
66,000 |
0 |
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2012-08-20 |
4 |
OE |
$5.69 |
$45,520 |
D/D |
8,000 |
74,000 |
0 |
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2013-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
21,125 |
87,125 |
0 |
- |
|
| RSPI |
RespireRx Pharmaceuticals... |
officerTitle |
– • – |
2005-02-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,500 |
0 |
|
- |
|
| RSPI |
RespireRx Pharmaceuticals... |
Director |
– • – |
2005-02-08 |
4 |
B |
$2.67 |
$6,675 |
D/D |
2,500 |
2,500 |
2.39 |
- |
|
| RSPI |
RespireRx Pharmaceuticals... |
Director |
– • – |
2005-02-09 |
4 |
OE |
$0.38 |
$5,682 |
D/D |
15,153 |
17,653 |
|
- |
|
| RSPI |
RespireRx Pharmaceuticals... |
officerTitle |
– • – |
2005-02-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,153 |
0 |
|
- |
|
| RSPI |
RespireRx Pharmaceuticals... |
Director |
– • – |
2007-11-30 |
4 |
B |
$0.50 |
$7,500 |
D/D |
15,000 |
15,000 |
2.39 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2015-12-14 |
4 |
B |
$2.90 |
$12,464 |
D/D |
4,200 |
4,200 |
2.39 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2019-12-24 |
4 |
D |
$40.64 |
$247,660 |
D/D |
(6,094) |
61,484 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2019-12-24 |
4 |
OE |
$3.24 |
$247,641 |
D/D |
67,578 |
67,578 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-03-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
21,484 |
21,484 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-03-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
21,484 |
40,000 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-07-01 |
4 |
AS |
$43.89 |
$131,677 |
D/D |
(3,000) |
37,000 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-08-03 |
4 |
AS |
$35.74 |
$107,213 |
D/D |
(3,000) |
34,000 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-08-18 |
4 |
OE |
$3.24 |
$85,413 |
D/D |
26,362 |
60,362 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-08-18 |
4 |
D |
$39.03 |
$85,437 |
D/D |
(2,189) |
58,173 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-09-01 |
4 |
AS |
$34.74 |
$104,207 |
D/D |
(3,000) |
55,173 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-10-01 |
4 |
AS |
$37.99 |
$113,956 |
D/D |
(3,000) |
52,173 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
